-- 
India Equities: Indian Banks, Educomp, HCL Infosystems, Panacea

-- B y   H e m a l   S a v a i
-- 
2011-08-18T10:39:21Z

-- http://www.bloomberg.com/news/2011-08-18/indian-equity-movers-hcl-infosystems-hotel-leela-idea-jet.html
Shares of the following companies
had unusual moves in Indian trading. Stock symbols are in
parentheses and prices are as of the 3:30 p.m. close in Mumbai.  India ’s Bombay Stock Exchange’s Sensitive Index, or Sensex,
declined 2.2 percent to 16,469.79. The BSE200 Index fell 2.2
percent to 2,038.45.  Indian Banks: Indian bank stocks dropped on speculation the
central bank may raise  interest rates  for a 12th time since
March 2010 to combat inflation, threatening company earnings.  ICICI Bank Ltd. (ICICIBC)  , India’s second-largest bank,
lost 5.1 percent to 863.8 rupees.  Axis Bank Ltd. (AXSB)  , sank
5.2 percent.  State Bank of India (SBIN)  Ltd, the county’s
largest lender, fell 4.2 percent to 2,078.4 rupees.  Educomp Solutions Ltd. (EDSL)  , the computer trainer,
tumbled 8.8 percent to 234.8 rupees, its lowest since April
2007, after ET Now television reported the company’s offices
were searched by income-tax authorities. Two calls made to the
mobile phone of Chairman and Managing Director Shantanu Prakash
weren’t answered.  HCL Infosystems Ltd. (HCLI)   dropped 9.7 percent to 67.05
rupees, the worst loss since February 2009. The Indian computer
maker reported fourth-quarter profit fell to 114.8 million
rupees ($2.5 million) from 672.3 million rupees a year ago, the
company said in a statement to the Bombay Stock Exchange
yesterday.  Panacea Biotec Ltd. (PNCB)   plunged 19.5 percent to 144.8
rupees, the most since Oct. 2008. The World Health Organisation
has delisted the company’s diphtheria-pertussis-tetanus-based
combination and hepatitis-B vaccines from its list of pre-
qualified medicines, the Indian company said in a release to the
Bombay Stock Exchange yesterday. Current batches that have
already been distributed are safe and will not be recalled.  To contact the reporters on this story:
Hemal Savai in Mumbai at  at
 hsavai@bloomberg.net   To contact the editor responsible for this story:
Darren Boey at 
 dboey@bloomberg.net  